---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-043134"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:41:22.515384+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals regains Nasdaq minimum bid price compliance after reverse stock split

## Summary
- Received Nasdaq letter on Oct 30, 2024 confirming full compliance with Minimum Bid Price Requirement.
- 1-for-15 reverse stock split effective Oct 16, 2024 helped meet the $1.00 bid price threshold.
- Nasdaq determined closing bid price was at or above $1.00 for 10 consecutive business days.
- Compliance matter is now closed, removing delisting risk from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-24-043134
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315224043134/0001493152-24-043134-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315224043134/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-043134
- JSON: https://secwatch.observer/filing/0001493152-24-043134.json
- Plain text: https://secwatch.observer/filing/0001493152-24-043134.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.